183 related articles for article (PubMed ID: 16193335)
1. Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma.
Zhou FL; Zhang WG; Chen G; Zhao WH; Cao XM; Chen YX; Tian W; Liu J; Liu SH
Cancer Immunol Immunother; 2006 Aug; 55(8):910-7. PubMed ID: 16193335
[TBL] [Abstract][Full Text] [Related]
2. [Immunological screening for multiple myeloma-associated antigens and their bioinformatics analysis].
Zhou FL; Zhang WG; Chen G; Zhao WH; Cao XM; Chen YX; Tian W; Liu SH; Wu MX; Liu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):252-7. PubMed ID: 16638191
[TBL] [Abstract][Full Text] [Related]
3. Identification and expression of MMSA-8, and its clinical significance in multiple myeloma.
He R; Yang N; Zhang P; Liu J; Li J; Zhou F; Zhang W
Oncol Rep; 2017 Jun; 37(6):3235-3243. PubMed ID: 28498418
[TBL] [Abstract][Full Text] [Related]
4. Serological identification and bioinformatics analysis of immunogenic antigens in osteosarcoma.
Liao B; Ma B; Liu Z; Zhang H; Long H; Yang T; Fan Q
Cancer Biol Ther; 2007 Nov; 6(11):1805-9. PubMed ID: 18032929
[TBL] [Abstract][Full Text] [Related]
5. A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
Lu C; Meng S; Jin Y; Zhang W; Li Z; Wang F; Wang-Johanning F; Wei Y; Liu H; Tu H; Su D; He A; Cao X; Zhou F
Br J Haematol; 2017 Aug; 178(3):413-426. PubMed ID: 28508448
[TBL] [Abstract][Full Text] [Related]
6. Identification of tumor-associated autoantigens with SEREX.
Türeci O; Usener D; Schneider S; Sahin U
Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
[TBL] [Abstract][Full Text] [Related]
7. Serological detection of cutaneous T-cell lymphoma-associated antigens.
Eichmuller S; Usener D; Dummer R; Stein A; Thiel D; Schadendorf D
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):629-34. PubMed ID: 11149944
[TBL] [Abstract][Full Text] [Related]
8. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
Jäger D
Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
[TBL] [Abstract][Full Text] [Related]
9. The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
Vaughan HA; St Clair F; Scanlan MJ; Chen YT; Maraskovsky E; Sizeland A; Old LJ; Cebon J
Cancer Immun; 2004 Jul; 4():5. PubMed ID: 15255672
[TBL] [Abstract][Full Text] [Related]
10. Exploitation of the B cell repertoire for the identification of human tumor antigens.
Pfreundschuh M
Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.
Wang Y; Wang P; Liu M; Zhang X; Si Q; Yang T; Ye H; Song C; Shi J; Wang K; Wang X; Zhang J; Dai L
J Immunol Methods; 2021 May; 492():112991. PubMed ID: 33587914
[TBL] [Abstract][Full Text] [Related]
12. Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).
Matsuzaki Y; Hashimoto S; Fujita T; Suzuki T; Sakurai T; Matsushima K; Kawakami Y
J Immunother; 2005; 28(1):10-9. PubMed ID: 15614040
[TBL] [Abstract][Full Text] [Related]
13. High throughput quantitative reverse transcription PCR assays revealing over-expression of cancer testis antigen genes in multiple myeloma stem cell-like side population cells.
Wen J; Li H; Tao W; Savoldo B; Foglesong JA; King LC; Zu Y; Chang CC
Br J Haematol; 2014 Sep; 166(5):711-9. PubMed ID: 24889268
[TBL] [Abstract][Full Text] [Related]
14. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
15. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies.
Wang Z; Zhang Y; Liu H; Salati E; Chiriva-Internati M; Lim SH
Blood; 2003 Feb; 101(3):955-60. PubMed ID: 12393489
[TBL] [Abstract][Full Text] [Related]
17. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
[TBL] [Abstract][Full Text] [Related]
18. Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line.
Zhou Y; Toth M; Hamman MS; Monahan SJ; Lodge PA; Boynton AL; Salgaller ML
Biochem Biophys Res Commun; 2002 Jan; 290(2):830-8. PubMed ID: 11785977
[TBL] [Abstract][Full Text] [Related]
19. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
Hybridoma; 1999 Feb; 18(1):23-8. PubMed ID: 10211784
[TBL] [Abstract][Full Text] [Related]
20. Immunomic analysis of human sarcoma.
Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
